| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/08/2003 | EP1349556A2 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages |
| 10/08/2003 | EP1349555A1 Treatment of cancer by reduction of intracellular energy and pyrimidines |
| 10/08/2003 | EP1349554A2 Compositions and methods for treating an arthritic condition |
| 10/08/2003 | EP1349553A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 10/08/2003 | EP1349552A1 Pyrazolo 3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists |
| 10/08/2003 | EP1349551A2 A method for treating erectile dysfunction |
| 10/08/2003 | EP1349550A1 Substituted-4-quinolones |
| 10/08/2003 | EP1349549A2 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides |
| 10/08/2003 | EP1349548A2 Methods and compositions for treating periodontal disease |
| 10/08/2003 | EP1349547A2 Use of 5-aminolevulinic acid for the prophylaxis of restenosis |
| 10/08/2003 | EP1349546A2 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect |
| 10/08/2003 | EP1349545A1 Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same |
| 10/08/2003 | EP1349542A1 Amoxycillin pellets |
| 10/08/2003 | EP1349541A1 Self emulsifying lipid matrix (selm) |
| 10/08/2003 | EP1349540A2 Topical alcoholic solution of a salicylic acid derivative and acemannan |
| 10/08/2003 | EP1349539A1 Biocompatible composite |
| 10/08/2003 | EP1349538A2 Skin care product containing retinoids, retinoid booster and phytoestrogens in a dual compartment package |
| 10/08/2003 | EP1349537A2 Skin care product containing retinoids and phytoestrogens in a dual compartment package |
| 10/08/2003 | EP1349531A1 Spaced drug delivery system |
| 10/08/2003 | EP1349485A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 10/08/2003 | EP1349457A1 Liquid antimicrobial compositions |
| 10/08/2003 | EP1272230B1 Injectable bone mineral substitute material comprising bone cement and oil |
| 10/08/2003 | EP1227808B1 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 10/08/2003 | EP1214318B1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 10/08/2003 | EP1198464B1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES |
| 10/08/2003 | EP1183014B1 Controlled release and taste masking oral pharmaceutical compositions |
| 10/08/2003 | EP1181285B1 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
| 10/08/2003 | EP1150683B1 Utilization of dienogest in high doses |
| 10/08/2003 | EP1144421B1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases |
| 10/08/2003 | EP1140934B1 Benzisoxazoles and phenones as alpha-2-antagonists |
| 10/08/2003 | EP1137398B1 Pharmaceutical preparation for inhalation of an opioid |
| 10/08/2003 | EP1123304B1 Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor |
| 10/08/2003 | EP1105377B1 Pyrimidinone derivatives for the treatment of atherosclerosis |
| 10/08/2003 | EP1079836B1 Use of danazol in the treatment of hyypogonadism in men |
| 10/08/2003 | EP1074556B1 Phosphonic acid diester derivatives |
| 10/08/2003 | EP1073455B1 Compositions and methods for extending the action of clostridial neurotoxin |
| 10/08/2003 | EP1070068B1 Granulatimide derivatives for use in cancer treatment |
| 10/08/2003 | EP1007018B1 The use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone in the treatment of tinnitus |
| 10/08/2003 | EP1003465B1 Prevention/retardation of hair growth |
| 10/08/2003 | EP1001935B1 Indole derivatives as mcp-1 receptor antagonists |
| 10/08/2003 | EP0994884B1 Diphosphonic acid salts for the treatment of osteoporosis |
| 10/08/2003 | EP0966245B1 Antimicrobial cosmetic compositions |
| 10/08/2003 | EP0951284B1 Phenylethylamine derivatives |
| 10/08/2003 | EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 10/08/2003 | EP0929299B1 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA(b)BENZOFURANS |
| 10/08/2003 | EP0927170B1 Piperazino derivatives as neurokinin antagonists |
| 10/08/2003 | EP0882707B1 Novel tricyclic compounds and drug compositions containing the same |
| 10/08/2003 | EP0882130B1 Human cancer antigen of tyrosinase-related protein 1 and gene encoding same |
| 10/08/2003 | EP0863740B1 Reduction of hair growth |
| 10/08/2003 | EP0818956B1 Cereal food product high in soluble fiber |
| 10/08/2003 | EP0814783B1 Multiple unit effervescent dosage forms comprising protonpump inhibitor |
| 10/08/2003 | EP0812319B9 2-arylbenzazole compounds |
| 10/08/2003 | EP0750628B1 Fibroblast growth factor-10 |
| 10/08/2003 | EP0533845B1 USING 5,10,15,20-TETRAKIS(r-CARBOXYPHENYL)PORPHINE FOR DETECTING AND TREATING LUNG CANCER |
| 10/08/2003 | CN1447920A Compsns. and methods for modulating tumor specific expression |
| 10/08/2003 | CN1447850A Purifying crude pufa oils |
| 10/08/2003 | CN1447820A Heparin-derived polysaccharide mixtures, prepn. method and pharmaceutical compsns. contg. same |
| 10/08/2003 | CN1447819A Human CYR 61 |
| 10/08/2003 | CN1447811A Medicinal compsns. and its use |
| 10/08/2003 | CN1447810A Bicyclo-pyrazoles active as kinase inhibitors,process for their prepn. and pharmaceutical compsns. comprising them |
| 10/08/2003 | CN1447809A Medicines for prevention and treatment of neurodegenerative diseases |
| 10/08/2003 | CN1447808A Oxazolidinone derivatives as anticrobials |
| 10/08/2003 | CN1447807A Chromenone derivatives and their use for treating diseases in conjunction with 5-HT1A receptors and/or dopamine D2 receptors |
| 10/08/2003 | CN1447806A 4-,5-,6-and 7-indole derivatives useful for treatment of CNS disorders |
| 10/08/2003 | CN1447805A Novel indole derivatives and their use as medicaments |
| 10/08/2003 | CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders |
| 10/08/2003 | CN1447799A Giphenyl derivatives and use thereof as integrin inhibitors |
| 10/08/2003 | CN1447796A Novel heteroaryl derivatives and use thereof as anti-tumour agents |
| 10/08/2003 | CN1447795A Biphenyl derivatives and use thereof as integrin inhibitors |
| 10/08/2003 | CN1447794A Novel compounds |
| 10/08/2003 | CN1447793A Prodrugs to NMDA receptor ligands |
| 10/08/2003 | CN1447792A Aporphine esters and their use in therapy |
| 10/08/2003 | CN1447791A 10-aryl-11-hbenzo [b] fluorene derivatives and analogs for medicinal use |
| 10/08/2003 | CN1447789A Compounds to treat alzheimer's disease |
| 10/08/2003 | CN1447697A Antitumor effect potentiators |
| 10/08/2003 | CN1447696A Gene detection assay for improving likelihood of effective response to erbb antagonist cancer therapy |
| 10/08/2003 | CN1447695A Potent immunostimulants from microalgae |
| 10/08/2003 | CN1447694A Rapid onset formulation |
| 10/08/2003 | CN1447693A Use of angiotensin Ôàí antagonists |
| 10/08/2003 | CN1447692A Methods of drug delivergy to hepatocytes and treatment of flaviviridae infections |
| 10/08/2003 | CN1447691A Pharmaceutical combination of angiotensin Ôàí antagonists and ace inhibitors |
| 10/08/2003 | CN1447690A Inhibition of cystic fibrosis transmembrane conductance regulator chloride channel |
| 10/08/2003 | CN1447689A Radioprotective agents |
| 10/08/2003 | CN1447688A Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid |
| 10/08/2003 | CN1447687A Compsns. for improving mental concentration |
| 10/08/2003 | CN1447686A D-Enantiomer of DFMO and methods of use thereof for treating cancer |
| 10/08/2003 | CN1447685A Process for decreasing cell proliferation based on (3R,4R)-Ôû�8-tetrahydrocannabinol)-11-acid |
| 10/08/2003 | CN1447684A Stable gabapentin having PH within controlled range |
| 10/08/2003 | CN1447683A Polymeric micelle compsns. |
| 10/08/2003 | CN1447682A Amphotericin B structured emulsion |
| 10/08/2003 | CN1447681A Storage stable tretinoin and 4-hydroxy anisole contg. topical compsn. |
| 10/08/2003 | CN1447680A Topical micronutrient delivery system and uses thereof |
| 10/08/2003 | CN1446907A Method for proliferating and differentiating nerve stem cells under medication inducement and its application |
| 10/08/2003 | CN1446818A Technique of preparing extract product of ÔÇÿLiangtoujianÔÇÖ and its application in preparing medication of treating cancer |
| 10/08/2003 | CN1446816A Compound of geniposide acid, gentio-bioside medication and its preparation method |
| 10/08/2003 | CN1446814A Method for preparing psoralen and isopsoralen |
| 10/08/2003 | CN1446813A Novel dihydric indole compound, their prepn. process and medicinal compsns. contg.them |
| 10/08/2003 | CN1446809A Derivant of new type sweetsop lactone as well as preparation method and usage |
| 10/08/2003 | CN1446790A Medicinal grade ferrum citricum iron-59 citrate and its preparation method |
| 10/08/2003 | CN1446585A Combination object of half solid framework preparation of gingko leaf extract product |